Neurosense Therapeutics Ltd.’s (NRSN) Moving Averages Convergence Divergence (MACD) indicator is -0.98, suggesting Neurosense Therapeutics Ltd. is a Sell.
Neurosense Therapeutics Ltd.’s (NRSN) 20-Day exponential moving average is $2.55, while Neurosense Therapeutics Ltd.’s (NRSN) share price is $1.42, making it a Sell.
Neurosense Therapeutics Ltd.’s (NRSN) 50-Day exponential moving average is $4.68, while Neurosense Therapeutics Ltd.’s (NRSN) share price is $1.42, making it a Sell.
Neurosense Therapeutics Ltd.’s (NRSN) 10-Day exponential moving average is $1.87, while Neurosense Therapeutics Ltd.’s (NRSN) share price is $1.42, making it a Sell.
Neurosense Therapeutics Ltd.’s (NRSN) 100-Day exponential moving average is $7.55, while Neurosense Therapeutics Ltd.’s (NRSN) share price is $1.42, making it a Sell.
Neurosense Therapeutics Ltd.’s (NRSN) stock price is $1.42 and Neurosense Therapeutics Ltd.’s (NRSN) 50-day simple moving average is $4.93, creating a Sell signal.
Neurosense Therapeutics Ltd.’s (NRSN) stock price is $1.42 and Neurosense Therapeutics Ltd.’s (NRSN) 100-day simple moving average is $8.44, creating a Sell signal.
Neurosense Therapeutics Ltd.’s (NRSN) stock price is $1.42 and Neurosense Therapeutics Ltd.’s (NRSN) 200-day simple moving average is $12.50, creating a Sell signal.